Cloxacillin Benzathine
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[[3-(2-chlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-, [2S-(2 ![]() ![]() ![]() (2S,5R,6R)-6-[3-(o-Chlorophenyl)-5-methyl-4-isoxazolecarboxamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid compound with N,N¢-dibenzylethylenediamine (2:1) ![]() ![]() ![]() » Cloxacillin Benzathine has a potency equivalent to not less than 704 µg and not more than 821 µg of cloxacillin (C19H18ClN3O5S) per mg, calculated on the anhydrous basis.
Packaging and storage—
Preserve in tight containers.
Labeling—
Label it to indicate that it is for veterinary use only. Where it is intended for use in preparing sterile dosage forms, the label states that it is sterile or must be subjected to further processing during the preparation of sterile dosage forms.
Identification—
Solutions:
Obtain the test solution as follows. To about 20 mg in a 50-mL conical flask, add 5 mL of 5 N sodium hydroxide, and heat on a steam bath for 20 minutes. Cool, transfer 1 mL of this solution to a separator containing 10 mL of 1.2 N sulfuric acid, and extract with 50 mL of ether. Wash the ether extract with 30 mL of water, and extract the ether layer with 50 mL of 0.1 N sodium hydroxide. Similarly prepare the Standard solution from about 15 mg of USP Cloxacillin Sodium RS.
Crystallinity
![]() ![]()
pH
![]() ![]()
Sterility
![]() ![]()
Water, Method I
![]() ![]()
Assay—
0.1 M Phosphate buffer—
Dissolve 55.2 g of monobasic sodium phosphate in water, and dilute with water to 4 L.
Mobile phase—
Combine 1000 mL of acetonitrile and 3000 mL of 0.1 M Phosphate buffer. Adjust with phosphoric acid or 1 N sodium hydroxide to a pH of 4.6 ± 0.2. Pass through a 0.45-µm nylon filter, and degas. [note—The retention time of cloxacillin is very sensitive to the acetonitrile content of the Mobile phase.]
Diluent—
Transfer 13.8 g of monobasic sodium phosphate to a 2-L volumetric flask, mix, and dilute with water to volume. Combine 1800 mL of the resulting solution with 1200 mL of acetonitrile. Adjust with phosphoric acid or 1 N sodium hydroxide to a pH of 6.4.
Standard preparations—
In duplicate, dissolve an accurately weighed quantity of USP Cloxacillin Sodium RS in Diluent to obtain solutions having known concentrations of about 112 µg per mL.
Assay preparations—
In duplicate, dissolve an accurately weighed quantity of Cloxacillin Benzathine in Diluent to obtain solutions having concentrations of about 128 µg per mL.
Chromatographic system (see Chromatography
![]() ![]() ![]()
Procedure—
Separately inject equal volumes (about 10 µL) of the Standard preparations and the Assay preparations into the chromatograph, record the chromatograms, and measure the areas for the major peaks. Calculate the quantity, in µg, of C19H18ClN3O5S in each mg of Cloxacillin Benzathine taken by the formula:
P(CS / CU)(rU / rS)
in which P is the assigned potency, in µg of cloxacillin per mg, of USP Cloxacillin Sodium RS; CS and CU are the concentrations, in µg per mL, of cloxacillin sodium and cloxacillin benzathine in the Standard preparations and the Assay preparations, respectively; and rU and rS are the average peak areas of the cloxacillin peaks obtained from the Assay preparations and the Standard preparations, respectively.
Auxiliary Information—
Please check for your question in the FAQs before contacting USP.
Chromatographic Column—
USP32–NF27 Page 2002
Pharmacopeial Forum: Volume No. 31(4) Page 1050
Chromatographic columns text is not derived from, and not part of, USP 32 or NF 27.
|